HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Restoration of plakoglobin expression in bladder carcinoma cell lines suppresses cell migration and tumorigenic potential.

Abstract
The reduction or loss of plakoglobin expression in late-stage bladder cancer has been correlated with poor survival where upregulation of this catenin member by histone deacetylase inhibitors has been shown to accompany tumour suppression in an in vivo model. In this study, we directly addressed the question of the role of plakoglobin in bladder tumorigenesis following restoration, or knockdown of expression in bladder carcinoma cell lines. Restoration of plakoglobin expression resulted in a reduction in migration and suppression of tumorigenic potential in vivo. Immunocytochemistry revealed cytoplasmic and membranous localisation of plakoglobin in transfectants with < 1% of cells displaying detectable nuclear localisation of plakoglobin. siRNA knockdown experiments targeting plakoglobin, revealed enhanced migration in all cell lines in the presence and absence of E-cadherin expression. In bladder cell lines expressing low levels of plakoglobin and desmoglein-2, elevated levels of desmoglein-2 were detected following restoration of plakoglobin expression in transfected cell lines. Analysis of wnt signalling revealed no activation event associated with plakoglobin expression in the bladder model. These results show that plakoglobin acts as a tumour suppressor gene in bladder carcinoma cells and the silencing of plakoglobin gene expression in late-stage bladder cancer is a primary event in tumour progression.
AuthorsK M Rieger-Christ, L Ng, R S Hanley, O Durrani, H Ma, A S Yee, J A Libertino, I C Summerhayes
JournalBritish journal of cancer (Br J Cancer) Vol. 92 Issue 12 Pg. 2153-9 (Jun 20 2005) ISSN: 0007-0920 [Print] England
PMID15942628 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cadherins
  • Cytoskeletal Proteins
  • DSG2 protein, human
  • Desmoglein 2
  • Desmogleins
  • Desmoplakins
  • Intercellular Signaling Peptides and Proteins
  • Wnt Proteins
  • gamma Catenin
Topics
  • Animals
  • Cadherins (biosynthesis)
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement (genetics)
  • Cytoskeletal Proteins (biosynthesis, genetics)
  • Desmoglein 2
  • Desmogleins
  • Desmoplakins
  • Disease Progression
  • Down-Regulation
  • Gene Expression
  • Gene Silencing
  • Genes, Tumor Suppressor (physiology)
  • Humans
  • Intercellular Signaling Peptides and Proteins (genetics)
  • Mice
  • Models, Animal
  • Neoplasm Invasiveness (genetics)
  • Neoplasm Staging
  • Signal Transduction (genetics)
  • Transfection
  • Urinary Bladder Neoplasms (genetics, metabolism, pathology)
  • Wnt Proteins
  • gamma Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: